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CONCLUSIONS 
The composite spheres presented a bioactive behaviour and high values of shape fixity and shape recovery confirmed the shape memory behaviour of the spheres triggered by hydration. 
The spheres were able to incorporate and release a drug model molecule. These spheres demonstrated to be attractive as bioactive multifunctional biomaterial for bone-related therapies. 
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INTRODUCTION 
Bioactive glass nanoparticles (BGNPs) promote an apatite surface layer in physiologic conditions that lead to a good interfacial bonding with bone.1 A strategy to induce bioactivity in non-bioactive 
polymeric biomaterials is to incorporate BGNPs in the polymer matrix. This combination creates a nanocomposite material with increased osteoconductive properties. Chitosan (CHT) is a polymer obtained 
by deacetylation of chitin and is biodegradable, non-toxic and biocompatible. The combination of CHT and the BGNPs aims at designing biocompatible spheres promoting the formation of a calcium 
phosphate layer at the nanocomposite surface, thus enhancing the osteoconductivity behaviour of the biomaterial. Shape memory polymers (SMP) are stimuli-responsive materials that offer mechanical 
and geometrical action triggered by an external stimulus.2 They can be deformed and fixed into a temporary shape which remains stable unless exposed to a proper stimulus that triggers recovery of their 
original shape. This advanced functionality makes such SMPs suitable to be implanted using minimally invasive surgery procedures. Regarding that, the inclusion of therapeutic molecules becomes 
attractive.  We propose the synthesis of shape memory bioactive nanocomposite spheres with drug release capability.3 
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RESULTS AND DISCUSSION 
The 10 wt % BGNPs content showed a rough surface with 
evenly distributed BGNPs protuberances. Indicating the 
successful BGNPs loading in the crosslinked CHT. 
Spheres with no BGNPs content and with lower crosslink 
(1% GNP content) showed higher strain recoveries. 
Spheres were capable to maintain the deformation and to 
recover their permanent shape. 
Formulations   Shape Fixity ratio (Rf) (%) 
Shape Recovery ratio (Rr) 
(%) 
 0%BGNPs10%GEN 72.67 ± 5.20 95.85 ± 9.14 
 5%BGNPs10%GEN  64.43 ± 11.00 99.19 ± 7.78 
 10%BGNPs10%GEN 71.47 ± 2.80 92.72 ± 4.63 
 20%BGNPs10%GEN 17.96 ± 4.90 93.17 ± 3.80 
 20%BGNPs1%GEN 70.55 ± 7.00 94.85 ± 5.44 
 20%BGNPs20%GEN 81.57 ± 8.70 88.76 ± 6.70 
Spheres completely occupied the bone defect, and 
accommodated trough a press-fitting effect. 
Higher release was achieved for the higher BGNPs 
content, while higher GNP content slowed the CR release. 
Apatite precipitates increased with SBF soaking time and 
revealed the cauliflower morphology of hydroxyapatite. 
As the amount of BGNPs increased, the relative intensity 
of the P and Ca peaks also increased, indicating a 
densification of the apatite layer. 
Ca/P ratios were close to 
the hydroxyapatite 
stoichiometric  
theoretical value (1.67). 
Formulations Ca/P 
10%BGNPs10%GNP 1.55 
20%BGNPs10%GNP 1.54 
40%BGNPs10%GNP 1.67 
50%BGNPs10%GNP 1.69 
60%BGNPs10%GNP 1.59 
20%BGNPs1%GNP 1.56 
20%BGNPs5%GNP 1.58 
20%BGNPs20%GNP 1.62 
After 7 days in SBF the apatite depots 
covered the entire surface of the spheres. 
BGNPs 
concentrated in 
one side of the 
spheres, and, 
their content 
was not equally 
distributed 
within the 
volume of the 
sphere.  
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MATERIALS AND METHODS 
1% (w/v) CHT was dissolved in an acetic acid 
solution 2% (v/v). Different contents of GNP (1, 5, 10 
and 20% w/w relatively to CHT) and BGNPs (0, 5, 10, 
20, 40, 50 and 60% w/w relatively to CHT) were 
added to the solution. A controlled volume of each 
formulation was dropped in a superhydrophobic 
surface. The crosslinking occurred for 24 h.  
 
 
 
 
 
To assess the shape memory capability, hydrated 
spheres were compressed and the stress was held 
constant while the sphere was immersed in pure 
ethanol for 30 min (maximum strain (Ԑm) of 75%). The 
stress was removed, and the sample acquired a 
temporary shape. Rf  characterized the ability of a 
system to fix the temporary shape and Rr was the 
recoverability of the permanent shape. They were 
calculated according to the equations (Ԑu was the 
fixed strain after unloading and Ԑp, the permanent 
strain after induced recovery): 
Rf(%)=Ԑu/Ԑm ×100         Rr(%)=1-(Ԑp/Ԑm) ×100  
 
 
 
 
To monitor of the shape memory capability of the 
s p h e r e s ; d e h y d r a t e d B G N P s s p h e r e s 
(10%BGNPs10%GNP) in the temporary shape were 
placed inside a 4 mm diameter rabbit femur defects. 
 
 
 
 
 
 
 
 
 
For drug delivery studies, Congo Red (CR) was 
loaded into the spheres. The spheres were pre-
deformed during 30 min by compression (Ԑm=75%). 
Then, they were immersed in a solution of 10 mg 
mL-1 of CR in PBS for 24 h. After loading, the 
samples were again compressed (Ԑm=75%) and 
dehydrated for 30 min in ethanol, and dried. After the 
deformation and fixation of the temporary shape, 
spheres were immersed in PBS. Aliquots were taken 
and CR was quantified by absorbance at 498 nm. 
 
 
 
 
In vitro bioactivity tests were carried out in simulated 
body fluid (SBF) for 1, 3 and 7 days at 37 ˚C. 
 
 
 
 
 
 
 
Micro-Computed Tomography (µ-CT) , SEM and EDS 
were used to assess the composition, morphology 
and behaviour of the spheres. 
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